Stock listing

NASDAQ:PRFX PRF Technologies Ltd. Stock

Home listing (NASDAQ) of PRF Technologies Ltd.

Follow PRF Technologies Ltd. into a list and get an email when it puts out news.

Share price · NASDAQ:PRFX

$0.476 USD -0.148 (-23.7%)

Close on Nov 20, 2026

Past year -89.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.460 – $0.601 USDNov 20, 2026
Volume
69,891 sharesNov 20, 2026
Market cap
$1.66M USDAt the close on Nov 20, 2026 · price × 3.50M shares outstanding
52-week range
$0.460 – $7.950 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$199,310 USDMedian day 48,728 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
PRF Technologies Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:PRFX · Home$0.476 USD-0.148 (-23.7%)69,891$0.601$0.601$0.460$0.623Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:PRFX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.476-0.148-23.7%$0.601$0.601$0.46069,891
$0.623-0.025-3.8%$0.640$0.640$0.60828,618
$0.648-0.013-2.0%$0.660$0.660$0.60446,079
$0.661-0.034-4.9%$0.700$0.700$0.66021,562
$0.695-0.088-11.2%$0.780$0.780$0.68087,065
$0.783-0.004-0.5%$0.738$0.866$0.697352,609
$0.787+0.043+5.8%$0.715$0.787$0.680273,366
$0.744-0.053-6.7%$0.820$0.820$0.67128,909
$0.797-0.015-1.8%$0.780$0.810$0.74020,711
$0.811-0.060-6.8%$0.827$0.887$0.76948,940
$0.871+0.112+14.8%$0.887$0.887$0.76272,346
$0.759-0.006-0.8%$0.778$0.800$0.74097,086
$0.765+0.054+7.6%$0.672$0.830$0.641448,820
$0.711-0.039-5.2%$0.770$0.777$0.7103,787,191
$0.750+0.020+2.7%$0.792$0.830$0.75022,777
$0.730-0.020-2.7%$0.732$0.742$0.71058,595
$0.750-0.030-3.9%$0.780$0.780$0.72530,041
$0.780+0.022+2.8%$0.760$0.824$0.7596,359
$0.759+0.019+2.6%$0.721$0.776$0.72134,386
$0.739-0.001-0.1%$0.740$0.760$0.72017,878
$0.740+0.020+2.8%$0.716$0.740$0.69854,731
$0.720-0.044-5.7%$0.752$0.752$0.70037,615
$0.764+0.039+5.4%$0.755$0.784$0.75318,106
$0.725+0.013+1.8%$0.750$0.785$0.72515,643
$0.712-0.069-8.9%$0.798$0.804$0.69181,930
$0.781-0.065-7.6%$0.812$0.833$0.7817,605
$0.846+0.027+3.3%$0.817$0.865$0.81036,404
$0.819+0.001+0.1%$0.835$0.840$0.81055,385
$0.818-0.042-4.9%$0.858$0.867$0.81244,041
$0.860-0.019-2.2%$0.910$0.915$0.85525,607
$0.879+0.020+2.4%$0.880$0.889$0.85531,839
$0.859-0.019-2.2%$0.886$0.894$0.85120,497
$0.878-0.002-0.3%$0.882$0.895$0.87817,702
$0.880-0.004-0.5%$0.895$0.925$0.88035,763
$0.884-0.036-3.9%$0.920$0.929$0.87268,902
$0.920-0.030-3.2%$0.920$0.939$0.91051,893
$0.9500.0000.0%$0.966$0.966$0.95022,957
$0.950+0.005+0.6%$0.967$0.978$0.95010,273
$0.945-0.027-2.7%$0.965$0.970$0.94511,829
$0.972-0.005-0.5%$0.990$1.020$0.96041,468
$0.977-0.005-0.5%$0.989$1.019$0.95043,478
$0.982-0.018-1.8%$1.000$1.010$0.971106,436
$1.000+0.070+7.5%$0.955$1.090$0.955164,331
$0.931-0.031-3.2%$0.977$0.993$0.90161,938
$0.962-0.058-5.7%$1.020$1.080$0.950127,345
$1.0200.0000.0%$1.050$1.060$1.00596,002
$1.020+0.010+1.0%$1.000$1.140$0.971276,133
$1.010+0.110+12.2%$0.911$1.270$0.9116,087,349
$0.900+0.039+4.6%$0.860$0.919$0.85579,478
$0.861+0.0000.0%$0.909$0.909$0.85523,811
$0.860-0.067-7.3%$0.912$0.930$0.85288,810
$0.928-0.023-2.4%$0.961$0.961$0.92151,380
$0.950+0.005+0.6%$0.983$0.983$0.93536,714
$0.945-0.023-2.4%$0.990$0.990$0.93026,621
$0.968-0.011-1.1%$0.999$1.000$0.92751,281
$0.979+0.005+0.5%$0.952$1.010$0.921724,827
$0.975+0.023+2.4%$0.936$0.979$0.93626,495
$0.951-0.002-0.3%$0.955$0.962$0.94021,258
$0.954-0.007-0.8%$0.960$0.995$0.94049,341
$0.961-0.026-2.6%$0.990$1.015$0.94241,970
$0.987+0.010+1.0%$0.990$1.020$0.98685,489
$0.977-0.018-1.8%$0.995$0.995$0.95064,803
$0.995-0.015-1.5%$1.030$1.050$0.98048,515
$1.010+0.013+1.3%$0.979$1.010$0.96049,502
$0.997-0.003-0.3%$1.000$1.050$0.98067,994
$1.000-0.010-1.0%$0.984$1.010$0.97153,221

Splits

3 splits since 2023 · NASDAQ:PRFX · every price before a split is adjusted for it

DayRatioWhat
1-for-5Consolidation
1-for-6Consolidation
1-for-10Consolidation
Ticker
NASDAQ:PRFX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All PRF Technologies Ltd. news

PRF Technologies Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
25 in the last 12 months · 86 in all · newest Nov 12, 2026 · oldest 2020
Decks
9 decks · latest April 2023

Where PRF Technologies Ltd. is listed

ListingExchangeCountryCurrency
NASDAQ:PRFX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:PRFXBOATSUnited StatesUSD

Valuation

EV/sales −249× against a median of 16.9×: the lowest of 6 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
−$9.82M USD
P/E
Loss
EV/sales
−249×
EV/EBITDA
Negative EBITDA
Price/book
0.1×
Gross margin
−307.6%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.0×
Beta vs S&P 500
1.93

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
PRF Technologies Ltd. · NASDAQ:PRFXUS$1.66M−US$9.82Mn/a−249×n/a0.1×n/a0.0×1.93
Genprex, Inc. · NASDAQ:GNPXUS$1.94M−US$13.41Mn/an/an/a0.1×n/a0.0×1.08
Propanc Biopharma, Inc. · NASDAQ:PPCBUS$1.84MUS$1.62Mn/an/an/a0.3×n/a0.0×1.39
Argent Biopharma Ltd · ASX:RGTUS$1.79MUS$8.05Mn/a75.4×n/an/an/an/an/a
Calidi Biotherapeutics, Inc. · AMEX:CLDIUS$1.76M−US$2.19Mn/an/an/a1.1×n/a0.0×1.86
Kala Bio, Inc. · NASDAQ:KALAUS$1.74M−US$5.49Mn/an/an/a0.2×n/a0.0×2.76
SOHM, Inc. · OTC:SHMNUS$1.74MUS$4.99Mn/a5.5×n/a0.5×−28.1%0.9×-0.10
Jupiter Neurosciences, Inc. · NASDAQ:JUNSUS$1.63MUS$1.33Mn/a16.9×n/an/an/an/a1.88
Kairos Pharma, Ltd. · AMEX:KAPAUS$1.48M−US$1.65Mn/an/an/a0.4×n/a0.0×1.36
BioRestorative Therapies, Inc. · NASDAQ:BRTXUS$1.45M−US$2.11Mn/a−5.9×n/a0.5×n/a0.0×1.81
Nutra Pharma Corp. · OTC:NPHCUS$1.43MUS$13.99Mn/a87.0×n/an/an/an/an/a
Median of the othersUS$1.74M−US$160,78116.9×0.4×−28.1%0.0×1.60

Forecasts

Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
12.00 USD · Analysts' mean

Team and board

Officers

OfficerRole
Ehud GellerExecutive Chairman & Interim CEO
Eyal BroderInterim CFO
Sigal AvielCOO
Rita KeynanVice President of Pharmaceutical Operations

Board

DirectorRole
Ehud GellerExecutive Chairman & Interim CEO
Asi ShavitDirector
Augustine LawlorDirector
Efi Cohen-AraziDirector
Ellen BaronDirector
Gus LawlorMember

Events

QuarterResultsShare move
Q3 2025Nov 27, 2025+4.3%
Q2 2025Aug 29, 2025−6.1%
Q1 2025Apr 7, 2025−16.3%
Quarter to Dec 31, 2024Mar 31, 2025+3.2%
Q3 2024Nov 12, 2024+3.2%
Q2 2024Aug 15, 2024 · After close+11.3%
Q1 2024May 15, 2024 · After close0.0%
Q4 2023Feb 29, 2024 · After close+21.4%
Q3 2023Nov 15, 2023 · After close−4.7%
Q2 2023Aug 10, 2023 · After close−0.4%
All 20 quarters
QuarterResultsShare move
Q1 2023May 16, 2023 · Before open+3.7%
Q4 2022Mar 15, 2023 · After close−0.9%
Q3 2022Nov 14, 2022 · After close−3.5%
Q2 2022Aug 15, 2022 · After close+0.1%
Q1 2022May 16, 2022 · After close+12.8%
Q4 2021Mar 17, 2022 · Before open−14.2%
Q3 2021Nov 15, 2021 · After close−9.4%
Q2 2021Aug 16, 2021 · Before open−5.6%
Quarter to Mar 31, 2021May 13, 2021 · Before open+5.6%
Quarter to Dec 31, 2020Mar 18, 2021 · After close−8.0%

Open Events

Decks

DeckKindSlidesDate
PainReform — Investor Presentation (April 2023)Investor deck19 slidesApril 2023
PainReform — Investor Presentation (July 2022)Investor deck19 slidesJul 29, 2022
PainReform — Investor Presentation (July 2022)Investor deck19 slidesJuly 2022
PainReform — Investor Presentation (April 2022)Investor deck19 slidesApril 2022
PainReform — Investor Presentation (July 2021)Investor deck16 slidesJuly 2021
PainReform — Investor Presentation (January 2021)Investor deck16 slidesJan 5, 2021
PainReform — Investor Presentation (January 2021)Investor deck16 slidesJanuary 2021
PainReform — Investor Presentation (October 2020)Investor deck19 slidesOctober 2020
PainReform — IPO Roadshow (August 2020)IPO roadshow19 slidesAugust 2020

Open Decks

Financings

RaiseDate
At-the-market programme of ordinary shares
Closed: US$900,000 raised
Apr 7, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Went public as PAINREFORM LTD. Priced at US$7.99 a share on Sep 1, 2020.

Price
US$7.99 a share
Units offered
2,500,000 units
Underwriters' option
Up to 375,000 more units
Listing
PRFX on the Nasdaq Capital Market
Underwriters
Maxim Group LLC, Joseph Gunnar & Co., LLC · In the order on the cover
Units delivered
On or about Sep 3, 2020

Steps

StepWhen
Draft sent to the SEC in confidenceFeb 3, 2020
Filed publiclyJun 30, 2020
Amended 4 timesNewest Aug 31, 2020
Shares registered with an exchangeAug 31, 2020
Declared effective by the SECAug 31, 2020
Final prospectus, with the priceSep 2, 2020

Open IPO · From the cover of the final prospectus (424B4) filed Sep 2, 2020

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue17.0K0086.0K0000
Cost of revenue70.0K0015.0K7.00K1.00K
Gross profit-827.0K-16.0K-15.0K71.0K-7.00K-1.00K
Research and development1.14M11.7M6.04M4.42M2.86M354.0K136.0K223.0K504.0K
Selling, general and administrative1.40M1.32M1.68M2.09M2.15M1.32M553.0K277.0K376.0K
Operating income-5.12M-14.7M-9.58M-8.87M-7.21M-1.67M-689.0K-500.0K-880.0K
Depreciation and amortization15.0K16.0K15.0K15.0K7.00K1.00K1.00K500.0K880.0K
EBITDA-5.11M-14.7M-9.57M-8.85M-7.20M-1.67M-688.0K00
Interest expense10.0K14.0K384.0K61.0K10.0K271.0K379.0K324.0K0
Income before tax-5.01M-14.6M-9.34M-8.78M-7.24M-3.83M-1.28M-828.0K-1.12M
Income tax8.00K8.00K8.00K9.00K6.00K220.0K04.00K-242.0K
Net income-5.02M-14.6M-9.34M-8.79M-7.25M-4.05M-1.28M-828.0K-2.09M
Earnings per share, basic-7.47-105.52-122.94-63.46-7.25-1.25-4.17-3.24-906.33
Earnings per share, diluted-7.47-105.52-122.94-63.46-7.25-1.25-4.17-3.24

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents3.13M4.26M8.03M4.10M16.5M15.7M941.0K46.0K187.0K
Short-term investments1.02M006.08M0
Receivables142.0K119.0K45.0K55.0K218.0K53.0K22.0K28.0K20.0K
Inventory7.82M2.23M2.04M6.00K
Current assets4.35M4.43M9.80M12.3M19.0M17.8M972.0K80.0K213.0K
Property, plant and equipment30.0K35.0K38.0K44.0K53.0K10.0K1.00K1.00K
Goodwill186.0K0
Total assets12.0M4.53M9.93M12.3M19.1M17.8M1.16M81.0K214.0K
Accounts payable213.0K296.0K221.0K209.0K136.0K720.0K22.0K2.00K64.0K
Current liabilities2.44M2.44M2.41M1.06M757.0K961.0K6.34M18.0K135.0K
Long-term debt4.52M
Total debt21.0K45.0K86.0K6.17M4.52M3.71M
Total liabilities2.71M2.70M2.69M1.31M991.0K1.18M6.79M4.54M3.84M
Shareholders' equity8.54M1.82M7.24M11.0M18.1M16.6M-12.2M-11.1M-3.63M
Shares outstanding830.6K341.8K165.5K1.08M10.5M8.76M576.6K10.5M2.31K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-3.96M-12.6M-6.68M-6.46M-6.55M-2.56M-609.0K-635.0K-870.0K
Capital spending-2.00K-13.0K-9.00K-6.00K-50.0K-10.0K0-10.0K-10.0K
Free cash flow-3.96M-12.6M-6.69M-6.46M-6.60M-2.57M-609.0K-635.0K-870.0K
Cash from investing-982.0K-13.0K5.99M-6.01M-50.0K-10.0K0-10.0K-10.0K
Cash from financing3.82M8.86M4.62M07.48M17.3M1.51M488.0K699.0K
Change in cash-1.12M-3.77M3.93M-12.5M881.0K14.7M901.0K-147.0K-171.0K

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13D/A · Big-stake notice, amendedNov 19, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerNov 13, 2026Current reportSEC
6-K · Report of a foreign issuerNov 12, 2026Current reportSEC
6-K · Report of a foreign issuerNov 5, 2026Current reportSEC
6-K · Report of a foreign issuerNov 3, 2026Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedNov 3, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerOct 23, 2026Current reportSEC
6-K · Report of a foreign issuerSep 28, 2026Current reportSEC
SCHEDULE 13D · Big-stake noticeSep 24, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerSep 16, 2026Current reportSEC
Show 200 filings
FilingDateTypeFiled with
6-K · Report of a foreign issuerSep 9, 2026Current reportSEC
EFFECT · Notice that a registration is effectiveSep 4, 2026Other filingsSEC
POS AM · Amendment to an effective registrationSep 3, 2026Offer documentSEC
6-K · Report of a foreign issuerSep 3, 2026Current reportSEC
6-K · Report of a foreign issuerJul 27, 2026Current reportSEC
6-K · Report of a foreign issuerJul 21, 2026Current reportSEC
6-K · Report of a foreign issuerJul 15, 2026Current reportSEC
6-K · Report of a foreign issuerJul 8, 2026Current reportSEC
EFFECT · Notice that a registration is effectiveJun 30, 2026Other filingsSEC
424B3 · ProspectusJun 29, 2026Offer documentSEC
CORRESP · Letter to the SECJun 29, 2026Other filingsSEC
UPLOAD · Letter from the SECJun 26, 2026Other filingsSEC
6-K · Report of a foreign issuerJun 25, 2026Current reportSEC
F-1 · Registration statementJun 22, 2026Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedJun 22, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerJun 18, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedJun 16, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerMay 28, 2026Current reportSEC
6-K · Report of a foreign issuerMay 26, 2026Current reportSEC
EFFECT · Notice that a registration is effectiveMay 20, 2026Other filingsSEC
424B3 · ProspectusMay 19, 2026Offer documentSEC
UPLOAD · Letter from the SECMay 18, 2026Other filingsSEC
CORRESP · Letter to the SECMay 18, 2026Other filingsSEC
F-1 · Registration statementMay 13, 2026Offer documentSEC
SCHEDULE 13G · Big-stake noticeMay 12, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerMay 7, 2026Current reportSEC
6-K · Report of a foreign issuerApr 28, 2026Current reportSEC
6-K · Report of a foreign issuerMar 27, 2026Current reportSEC
20-F · Annual reportMar 26, 2026Annual reportSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
6-K · Report of a foreign issuerMar 17, 2026Current reportSEC
6-K · Report of a foreign issuerMar 3, 2026Current reportSEC
6-K · Report of a foreign issuerFeb 18, 2026Current reportSEC
6-K · Report of a foreign issuerFeb 11, 2026Current reportSEC
6-K · Report of a foreign issuerFeb 3, 2026Current reportSEC
6-K · Report of a foreign issuerJan 20, 2026Current reportSEC
6-K · Report of a foreign issuerJan 15, 2026Current reportSEC
6-K · Report of a foreign issuerJan 12, 2026Current reportSEC
6-K · Report of a foreign issuerJan 7, 2026Current reportSEC
6-K · Report of a foreign issuerJan 6, 2026Current reportSEC
6-K · Report of a foreign issuerJan 5, 2026Current reportSEC
6-K · Report of a foreign issuerDec 30, 2025Current reportSEC
6-K · Report of a foreign issuerDec 10, 2025Current reportSEC
6-K · Report of a foreign issuerDec 2, 2025Current reportSEC
6-K · Report of a foreign issuerNov 25, 2025Current reportSEC
6-K · Report of a foreign issuerNov 12, 2025Current reportSEC
6-K · Report of a foreign issuerNov 5, 2025Current reportSEC
6-K · Report of a foreign issuerOct 1, 2025Current reportSEC
6-K · Report of a foreign issuerAug 19, 2025Current reportSEC
6-K · Report of a foreign issuerAug 13, 2025Current reportSEC
6-K · Report of a foreign issuerJul 10, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveMay 12, 2025Other filingsSEC
424B3 · ProspectusMay 9, 2025Offer documentSEC
CORRESP · Letter to the SECMay 7, 2025Other filingsSEC
6-K · Report of a foreign issuerMay 7, 2025Current reportSEC
UPLOAD · Letter from the SECMay 7, 2025Other filingsSEC
F-3 · Registration statementMay 2, 2025Offer documentSEC
SCHEDULE 13G · Big-stake noticeApr 24, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerApr 17, 2025Current reportSEC
6-K · Report of a foreign issuerApr 11, 2025Current reportSEC
6-K · Report of a foreign issuerApr 10, 2025Current reportSEC
6-K · Report of a foreign issuerApr 7, 2025Current reportSEC
20-F · Annual reportApr 7, 2025Annual reportSEC
6-K · Report of a foreign issuerApr 3, 2025Current reportSEC
6-K · Report of a foreign issuerMar 5, 2025Current reportSEC
6-K · Report of a foreign issuerFeb 27, 2025Current reportSEC
6-K · Report of a foreign issuerFeb 26, 2025Current reportSEC
6-K · Report of a foreign issuerFeb 18, 2025Current reportSEC
424B5 · ProspectusJan 2, 2025Offer documentSEC
6-K · Report of a foreign issuerJan 2, 2025Current reportSEC
6-K · Report of a foreign issuerDec 27, 2024Current reportSEC
EFFECT · Notice that a registration is effectiveDec 13, 2024Other filingsSEC
424B3 · ProspectusDec 12, 2024Offer documentSEC
CORRESP · Letter to the SECDec 11, 2024Other filingsSEC
UPLOAD · Letter from the SECDec 11, 2024Other filingsSEC
F-3 · Registration statementDec 6, 2024Offer documentSEC
6-K · Report of a foreign issuerDec 4, 2024Current reportSEC
6-K · Report of a foreign issuerNov 20, 2024Current reportSEC
6-K · Report of a foreign issuerNov 18, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 13, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerNov 12, 2024Current reportSEC
6-K · Report of a foreign issuerNov 7, 2024Current reportSEC
6-K · Report of a foreign issuerNov 4, 2024Current reportSEC
6-K · Report of a foreign issuerOct 16, 2024Current reportSEC
424B5 · ProspectusOct 16, 2024Offer documentSEC
6-K · Report of a foreign issuerOct 10, 2024Current reportSEC
6-K · Report of a foreign issuerOct 7, 2024Current reportSEC
EFFECT · Notice that a registration is effectiveOct 4, 2024Other filingsSEC
CORRESP · Letter to the SECOct 1, 2024Other filingsSEC
6-K · Report of a foreign issuerSep 30, 2024Current reportSEC
UPLOAD · Letter from the SECSep 24, 2024Other filingsSEC
F-3 · Registration statementSep 20, 2024Offer documentSEC
6-K · Report of a foreign issuerSep 11, 2024Current reportSEC
6-K · Report of a foreign issuerSep 10, 2024Current reportSEC
6-K · Report of a foreign issuerSep 4, 2024Current reportSEC
EFFECT · Notice that a registration is effectiveAug 30, 2024Other filingsSEC
SC 13D/A · Big-stake notice, amendedAug 29, 2024Big-stake noticeSEC
6-K/A · Report of a foreign issuer, amendedAug 28, 2024Current reportSEC
POS AM · Amendment to an effective registrationAug 27, 2024Offer documentSEC
6-K · Report of a foreign issuerAug 26, 2024Current reportSEC
SC 13D · Big-stake noticeAug 26, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerAug 15, 2024Current reportSEC
6-K · Report of a foreign issuerAug 13, 2024Current reportSEC
6-K · Report of a foreign issuerJul 9, 2024Current reportSEC
6-K · Report of a foreign issuerJun 26, 2024Current reportSEC
6-K · Report of a foreign issuerMay 31, 2024Current reportSEC
6-K · Report of a foreign issuerMay 15, 2024Current reportSEC
SC 13G · Big-stake noticeApr 24, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerApr 17, 2024Current reportSEC
424B3 · ProspectusApr 17, 2024Offer documentSEC
424B4 · ProspectusApr 17, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveApr 17, 2024Other filingsSEC
6-K · Report of a foreign issuerApr 16, 2024Current reportSEC
F-1/A · Registration statement, amendedApr 15, 2024Offer documentSEC
6-K · Report of a foreign issuerApr 9, 2024Current reportSEC
6-K · Report of a foreign issuerApr 8, 2024Current reportSEC
6-K · Report of a foreign issuerApr 2, 2024Current reportSEC
EFFECT · Notice that a registration is effectiveMar 15, 2024Other filingsSEC
POS AM · Amendment to an effective registrationMar 13, 2024Offer documentSEC
6-K · Report of a foreign issuerMar 7, 2024Current reportSEC
F-1 · Registration statementMar 1, 2024Offer documentSEC
6-K · Report of a foreign issuerMar 1, 2024Current reportSEC
20-F · Annual reportFeb 29, 2024Annual reportSEC
SC 13G/A · Big-stake notice, amendedFeb 15, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedJan 23, 2024Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveJan 22, 2024Other filingsSEC
424B3 · ProspectusJan 19, 2024Offer documentSEC
CORRESP · Letter to the SECJan 18, 2024Other filingsSEC
UPLOAD · Letter from the SECJan 18, 2024Other filingsSEC
F-3 · Registration statementJan 12, 2024Offer documentSEC
6-K · Report of a foreign issuerJan 3, 2024Current reportSEC
424B3 · ProspectusDec 27, 2023Offer documentSEC
6-K · Report of a foreign issuerDec 27, 2023Current reportSEC
6-K · Report of a foreign issuerDec 26, 2023Current reportSEC
6-K · Report of a foreign issuerNov 15, 2023Current reportSEC
6-K · Report of a foreign issuerSep 11, 2023Current reportSEC
424B3 · ProspectusSep 5, 2023Offer documentSEC
EFFECT · Notice that a registration is effectiveSep 5, 2023Other filingsSEC
CORRESP · Letter to the SECAug 30, 2023Other filingsSEC
UPLOAD · Letter from the SECAug 30, 2023Other filingsSEC
F-1 · Registration statementAug 25, 2023Offer documentSEC
6-K · Report of a foreign issuerAug 10, 2023Current reportSEC
6-K · Report of a foreign issuerJul 19, 2023Current reportSEC
424B5 · ProspectusJul 18, 2023Offer documentSEC
6-K · Report of a foreign issuerJul 18, 2023Current reportSEC
6-K · Report of a foreign issuerJul 14, 2023Current reportSEC
424B5 · ProspectusJul 14, 2023Offer documentSEC
6-K · Report of a foreign issuerJul 14, 2023Current reportSEC
6-K · Report of a foreign issuerJul 12, 2023Current reportSEC
6-K · Report of a foreign issuerJun 29, 2023Current reportSEC
6-K · Report of a foreign issuerJun 8, 2023Current reportSEC
6-K · Report of a foreign issuerJun 7, 2023Current reportSEC
6-K · Report of a foreign issuerMay 18, 2023Current reportSEC
6-K · Report of a foreign issuerMay 15, 2023Current reportSEC
6-K/A · Report of a foreign issuer, amendedMay 4, 2023Current reportSEC
6-K · Report of a foreign issuerMay 3, 2023Current reportSEC
6-K · Report of a foreign issuerMay 1, 2023Current reportSEC
6-K · Report of a foreign issuerMar 28, 2023Current reportSEC
6-K · Report of a foreign issuerMar 16, 2023Current reportSEC
20-F · Annual reportMar 15, 2023Annual reportSEC
6-K · Report of a foreign issuerMar 14, 2023Current reportSEC
SC 13G/A · Big-stake notice, amendedMar 2, 2023Big-stake noticeSEC
6-K · Report of a foreign issuerFeb 7, 2023Current reportSEC
6-K · Report of a foreign issuerDec 29, 2022Current reportSEC
6-K · Report of a foreign issuerNov 25, 2022Current reportSEC
6-K · Report of a foreign issuerNov 15, 2022Current reportSEC
6-K · Report of a foreign issuerNov 14, 2022Current reportSEC
6-K · Report of a foreign issuerNov 8, 2022Current reportSEC
6-K · Report of a foreign issuerOct 4, 2022Current reportSEC
6-K · Report of a foreign issuerAug 16, 2022Current reportSEC
6-K · Report of a foreign issuerAug 15, 2022Current reportSEC
6-K · Report of a foreign issuerJul 29, 2022Current reportSEC
S-8 · Registration statement for employee plansJun 29, 2022Offer documentSEC
6-K · Report of a foreign issuerMay 17, 2022Current reportSEC
6-K · Report of a foreign issuerMay 16, 2022Current reportSEC
6-K · Report of a foreign issuerMar 17, 2022Current reportSEC
20-F · Annual reportMar 16, 2022Annual reportSEC
SC 13G/A · Big-stake notice, amendedFeb 11, 2022Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedJan 25, 2022Big-stake noticeSEC
6-K · Report of a foreign issuerDec 9, 2021Current reportSEC
6-K · Report of a foreign issuerNov 16, 2021Current reportSEC
6-K · Report of a foreign issuerNov 15, 2021Current reportSEC

This page holds 200 of 266 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from PRF Technologies Ltd.’s releases · as of Apr 7, 2025

Common shares
3,499,144
Fully diluted
3,499,144

Fully diluted

LineShares
Common shares3,499,144

Share count over time

CountShares
Nov 22, 20263,499,144

Open Cap table

Shareholders

HolderSharesValueAs of
Blackstone Alternative Multi-Strategy Fund41US$57Jun 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Augustine Lawlor
Other companies: Cypherpunk Technologies Inc. (Chief Operating Officer · Since at least Jan 20, 2017); Gyre Therapeutics, Inc. (Director · Aug 20, 2015 – Aug 31, 2023 · Past); Globeimmune Inc (Director · Jul 1, 2014 – Mar 18, 2016 · Past); Cardiovascular Systems Inc (Director · Aug 31, 2012 – Apr 27, 2023 · Past); Human Genome Sciences Inc (Director · Oct 10, 2011 – Jul 30, 2012 · Past)
Director · Since at least Mar 18, 2026
Efraim Cohen Arazi
Other companies: Regentis Biomaterials Ltd. (Director · Since at least Mar 18, 2026)
Interim CEO, Director · Since at least Mar 18, 2026
Ehud Geller
Other companies: Regentis Biomaterials Ltd. (CEO & Chairman · Since at least Mar 18, 2026)
Executive Chairman & Interim CEO · Since at least Mar 18, 2026
Asi ShavitDirector · Since at least Nov 5, 2026
Efi Cohen AraziDirector · Since at least Jul 21, 2026
Ellen BaronDirector · Since at least Mar 18, 2026
Eyal BroderInterim CFO · Since at least Nov 5, 2026
Gus LawlorMember · Since at least Nov 4, 2026
Rita KeynanVice President of Pharmaceutical Operations · Since at least Nov 5, 2026
Sigal AvielCOO · Since at least Mar 18, 2026

Open People

Log in to ask 6ix AI your own questions about PRF Technologies Ltd.